US FDA Advisory Committee Formats Can Spur Unhealthy Dynamics – Califf

US Food and Drug Administration Commissioner Robert Califf is raising concerns about how current advisory committee formats can influence meeting outcomes, and perhaps not for the better, as the agency undergoes a “stem to stern review” of the process for making key recommendations on drug approvals.

“If you get a bunch of people that get a book this thick and then show up in a room at eight o'clock in the morning, and they can't talk to each other in between, there's some dynamics that go on in the room that I don't think are the most